Nokia deploys future-ready network architecture to enhance Zayo’s leading IP network infrastructure

Nokia deploys future-ready network architecture to enhance Zayo's leading IP network infrastructure GlobeNewswire October 29, 2025 Press ReleaseNokia deploys future-ready network architecture to enhance Zayo's leading IP network infrastructure Upgraded IP network architecture to provide Zayo's customers with faster, broader set of services including cloud access, data center connectivity, and secure high-speed links First phase […]

NXP Improves Battery Health Monitoring with EIS Capable Battery Management Chipset

NXP Improves Battery Health Monitoring with EIS Capable Battery Management Chipset GlobeNewswire October 29, 2025 NXP unveils industry-first, battery management system (BMS) chipset with built-in Electrochemical Impedance Spectroscopy (EIS) using precise hardware-based synchronization of all battery cell measurements within a single high-voltage battery pack Brings lab-grade diagnostics into vehicles, enhancing battery health insights and expanding

Discover China’s Multiverse in Shandong

A news report fromChina Daily: Join a foreign couple on “Journey to the East” as they explore Jinan and Qingdao in Shandong! The video unlocks China's multiverse – poetic, culinary, romantic, cinematic, historical and flavorful. Witness Baotu Spring's timeless charm, savor authentic Shandong cuisine, sip iconic Tsingtao Beer, and step onto a film production set

NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem’s Shares

NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) (“NLS” or the “Company”) andKadimastem Ltd. (TASE: KDST) (“Kadimastem”) today announced that, following the receipt of Nasdaq's approval for the listing of the Company's common shares and the trading of the Company on the Nasdaq Capital Market after completion of the mergerbetween the Company, NLS Pharmaceutics (Israel) Ltd.,

Senzime Q3 2025: Strong Growth and Clear Steps Towards Profitability

UPPSALA, SE / ACCESS Newswire / October 29, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) – Senzime AB’s (publ) interim report for January – September 2025 is now available on the company’s website www.senzime.com . Strategic events during and after the end of the third quarter Additional strategic hospital contracts secured in the U.S. market. First-ever guidelines issued

Mobileye Expands India Footprint, Collaborates with VVDN Technologies to Localize Next-Generation ADAS Tech for India and Beyond

Companies to localize key components of Mobileye Tech to accelerate Made-In-India to support Indian OEMs. https://www.vvdntech.com/ Mobileye, a global leader in advanced driver assistance systems and autonomous driving technologies, announced today it has signed a Memorandum of Understanding (MoU) with VVDN Technologies Pvt. Ltd., a leading Indian Tier 1, engineering and manufacturing services company, to

Under the supervision of the Ministry of Energy, Saudi Electricity Company and EDF power solutions win a 600 MW solar PV power project in Samtah and sign the Power Purchase Agreement with the Principal Buyer

— Consortium formed by Saudi Electricity company and EDF power solutions signs 25-year Power Purchase Agreement for the Samtah solar project in the frame of the Round 6 launched by the Saudi Power Procurement company (SPPC) — Consortium will develop, finance and operate the Samtah solar PV project with a capacity of 600 megawatts (MW)

What Hebei Can OfferäBiomedicine and Beyond

A News Report from Great Wall New Media — AmongHebei Province's 107 key specialized industrial clusters, the biopharmaceutical cluster inShijiazhuang High-Tech Zonehas emerged as a model of high-quality development and a key engine driving Hebei's integration into the global health industry chain. The cluster has established a comprehensive industrial system covering R&D, manufacturing, distribution, and

BioInvent International AB: Interim Report January – September 2025

LUND, SE / ACCESS Newswire / October 29, 2025 / BioInvent International (STO:BINV) "The third quarter of 2025 marked continued momentum for BioInvent as we decided to focus on our most advanced programs BI-1206 and BI-1808. This strategic direction initiative is designed to accelerate the development of our most promising clinical assets and to focus

Spago Nanomedical Interim Report January-September 2025

LUND, SE / ACCESS Newswire / October 29, 2025 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) JULY – SEPTEMBER IN BRIEF Net sales for the quarter amounted to KSEK 14 (KSEK 485) The loss for the quarter amounted to KSEK -6,265 (KSEK -8,763) Operating expenses for the quarter amounted to KSEK -7,568 (KSEK -10,650) Earnings per share, before

Scroll to Top